Octocog alfa - paediatric investigation plan
Octocog alfa
PIPHuman
Key facts
- Invented name
- Advate
- Advate
- Active Substance
- Octocog alfa
- Therapeutic area
- Haematology-Hemostaseology
- Decision number
- P/65/2010
- PIP number
- Octocog alfa
- Pharmaceutical form(s)
- Powder and solvent for solution for injection
- Condition(s) / indication(s)
- Haemophilia A (congenital Factor VIII deficiency)
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Baxter AG
E-mail: juliana_brankova@baxter.com
Country: Austria
Phone: +43 1201002548
Fax: + 43 120100727- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date